{{medical}}
{{Infobox disease
| Name           = 吉特曼氏綜合症<br>({{lang|en|Gitelman syndrome}})
| Image          = 
| Caption        = 
| DiseasesDB     = 31860 
| ICD10          = {{ICD10|N|25|8|n|25}} + {{ICD10|E|87|6|e|70}} + {{ICD10|E|83|4|e|70}} 
| ICD9           = 
| ICDO           = 
| OMIM           = 263800 
| MedlinePlus    = 
| eMedicineSubj  = article
| eMedicineTopic = 238670
| MeshID         = D053579 
}}

'''吉特曼氏綜合症'''（{{lang-en|Gitelman syndrome}}），又稱'''吉特曼症候群'''<ref name="kmu">{{cite journal | author =李雅婷、王一帆、林宗憲、黃洽鑽 | title =吉特曼症候群：三個病例報告與文獻回顧 | journal = | volume = | issue = | pages = |year=2006 | pmid = | doi = | url =http://ir.lib.kmu.edu.tw/bitstream/310902000/12710/1/PIIS1607551X09703237.pdf | issn = }}</ref>
，是一種常染色體隱性腎臟疾病，其特點是[[低鈣尿症|低鈣]]（hypocalciuria）、及[[低鎂血症|低鎂]]（hypomagnesemia）之[[低鉀血症|低鉀]][[代謝性鹼中毒|代謝性鹼中毒]]（Metabolic alkalosis）。它是由位在[[遠曲小管|遠曲小管]]（distal convoluted tubule）的[[噻嗪類|噻嗪類]]（thiazide）相關[[鈉氯同向轉運體|鈉氯同向轉運體]]（sodium-chloride symporter、亦稱為NCC、 NCCT、或TSC）的失活突變（inactivating mutation）所造成的功能喪失。<ref name="pmid8528245">{{cite journal | author = Simon DB, Nelson-Williams C, Bia MJ, Ellison D, Karet FE, Molina AM, Vaara I, Iwata F, Cushner HM, Koolen M, Gainza FJ, Gitleman HJ, Lifton RP | title = Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. | journal = Nat. Genet. | volume = 12 | issue = 1 | pages = 24–30 | date = Jan 1996 | pmid = 8528245 | doi = 10.1038/ng0196-24 | url = http://www.ncbi.nlm.nih.gov/pubmed?term=david%20b%20simon%20gitelman's%20variant | issn =  | access-date = 2014-12-06 | archive-date = 2019-06-13 | archive-url = https://web.archive.org/web/20190613152842/https://www.ncbi.nlm.nih.gov/pubmed?term=david%20b%20simon%20gitelman's%20variant | dead-url = no }}</ref>

吉特曼氏綜合症以前被認為包括在[[巴特氏症候群|巴特氏症候群]]裡，直到對這些疾病的不同的基因及分子基礎進行過鑑定。巴特氏症候群也是一種常染色體隱性低鉀代謝性鹼中毒，但它被發現在[[亨利氏環|亨利氏環]]（loop of Henle）[[亨利氏環升序肢體|升序肢體]]（Ascending limb of loop of Henle）裡從一個突變派生到[[鈉鉀氯共轉運蛋白|NKCC2]]。<ref name="pmid8640224">{{cite journal | author = Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP | title = Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2 | journal = Nat. Genet. | volume = 13 | issue = 2 | pages = 183–8 |date=June 1996 | pmid = 8640224 | doi = 10.1038/ng0696-183 | url = | issn = }}</ref>

==病因==
{{seealso|腎功能|腎生理學}}
<!--
[[Image:Gitelman_syndrome.jpg|thumb]]. Sodium-chloride (NaCl) enters the cell via the apical thiazide-sensitive NCC and leaves the cell through the basolateral Cl<sup>−</sup> channel (ClC-Kb), and the Na+/K+-ATPase. Indicated also are the recently identified magnesium channel TRPM6 in the apical membrane, and a putative Na/Mg exchanger in the basolateral membrane. These transport mechanisms play a role in familial hypokalemia-hypomagnesemia or Gitelman's syndrome.]]
[[Image:autorecessive.svg|thumb]] pattern of inheritance.]]-->

吉特曼氏綜合症鏈接到[[鈉氯同向轉運體|SLC12A3]]基因"失活的突變"造成編碼的敏感[[噻嗪類|噻嗪類]]（Thiazide）[[鈉氯同向轉運體|鈉氯同向轉運體]]（NCCT）的功能喪失。<!--This cell membrane protein participates in the control of ion [[homeostasis|homeostasis]] at the [[distal_convoluted_tubule|distal convoluted tubule]] portion of the [[nephron|nephron]].

Gitelman's syndrome is an [[autosome|autosomal]]-recessive disorder: one defective [[allele|allele]] has to be inherited from each parent.-->

==描述==
吉特曼氏綜合症病患所出現的症狀相同於服用[[噻嗪類|噻嗪類]][[利尿劑|利尿劑]]的病患所出現的症狀。<ref name="pmid15085183">{{cite journal |author=O'Shaughnessy KM, Karet FE |title=Salt handling and hypertension |url=https://archive.org/details/sim_journal-of-clinical-investigation_2004-04_113_8/page/1075 |journal=J. Clin. Invest. |volume=113 |issue=8 |pages=1075–81 |year=2004 |pmid=15085183 |doi=10.1172/JCI200421560 |pmc=385413}}</ref>

本病的臨床症狀是[[低氯血症|低氯血性]]（hypochloremia）[[代謝性鹼中毒|代謝性鹼中毒]]（metabolic alkalosis）、[[低鉀血症|低鉀血症]]，及[[低鈣尿症|低鈣尿症]]（hypocalciuria）。<!--[[Hypomagnesemia|Hypomagnesemia]] is present in many but not all cases. In contrast to patients with [[Pseudohypoaldosteronism|Gordon's syndrome]], those suffering from Gitelman's syndrome are generally normotensive. Carriers of Gitelman's syndrome-linked mutations are often asymptomatic while some complain of mild muscular [[cramp|cramp]]s or weakness expressed as fatigue or irritability. More severe symptoms such as [[tetany_(medical_sign)|tetany]] and [[paralysis|paralysis]] have however also been reported. Phenotypic variations observed among patients probably result from differences in their genetic background and may depend on which particular amino acid in the NCCT protein has been mutated.

See Naesens ''et al.'' for a recent review.<ref name="pmid15056980">{{cite journal |author=Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D |title=Bartter's and Gitelman's syndromes: from gene to clinic |journal=Nephron. Physiology |volume=96 |issue=3 |pages=p65–78 |year=2004 |pmid=15056980 |doi=10.1159/000076752}}</ref>-->

==命名==
它以一位美國醫生[[希勒爾·J.·吉特曼|希勒爾·J.·吉特曼]]（Hillel J. Gitelman、1932-2015）而命名。<ref>{{WhoNamedIt|synd|2329}}</ref><ref name="pmid5929460">{{cite journal |author=Gitelman HJ, Graham JB, Welt LG |title=A new familial disorder characterized by hypokalemia and hypomagnesemia |journal=Trans. Assoc. Am. Physicians |volume=79 |issue= |pages=221–35 |year=1966 |pmid=5929460 |doi=}}</ref><ref>{{cite journal | author=Unwin RJ, Capasso G | title=Bartter's and Gitelman's syndromes: their relationship to the actions of loop and thiazide diuretics | journal=CURRENT OPINION IN PHARMACOLOGY | volume=6 | issue=2 | year=2006 | pages=208–213 | url=http://147.83.15.91/Doc/cols_new/contenidos/data/072854502093.3.Sindromes_Gitelman_Barter.pdf | format=[[PDF|PDF]] | id= | pmid=16490401 | doi=10.1016/j.coph.2006.01.002 | deadurl=yes | archiveurl=https://web.archive.org/web/20131023060532/http://147.83.15.91/Doc/cols_new/contenidos/data/072854502093.3.Sindromes_Gitelman_Barter.pdf | archivedate=2013-10-23 | access-date=2014-12-06 }}</ref><ref>{{Cite web |url=https://paw.princeton.edu/memorial/hillel-j-gitelman-%E2%80%9954 |title=存档副本 |accessdate=2020-08-07 |archive-date=2017-03-26 |archive-url=https://web.archive.org/web/20170326230329/https://paw.princeton.edu/memorial/hillel-j-gitelman-%E2%80%9954 |dead-url=no }}</ref>

==參見==
*[[協同轉運蛋白|協同轉運蛋白]]（Cotransporter）

==註釋==
{{reflist|2}}

==外部連結==
* [http://www.barttersite.org The Bartter Site] {{Wayback|url=http://www.barttersite.org/ |date=20200805011324 }}

{{Nephrology}}
{{Solute carrier disorders}}

{{DEFAULTSORT:Gitelman Syndrome}}
[[Category:常染色体隐性遗传疾病|Category:常染色体隐性遗传疾病]]
[[Category:膜转运蛋白疾病|Category:膜转运蛋白疾病]]
[[Category:肾脏疾病|Category:肾脏疾病]]
[[Category:罕見疾病|Category:罕見疾病]]
[[Category:人名疾病|Category:人名疾病]]